# Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome

> **NCT00738400** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 150 (actual)

## Conditions studied

- Erectile Dysfunction
- Metabolic Syndrome

## Interventions

- **DRUG:** Vardenafil (Levitra, BAY38-9456)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00738400
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2015-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738400, "Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00738400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*